Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression

Documenti analoghi

• Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression
  di: Takashi Shimizu, et al.
  Pubblicazione: (2026-03-01)
• Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers
  di: Makoto Watanabe, et al.
  Pubblicazione: (2025-07-01)
• Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies
  di: Ryotaro Ohkuma, et al.
  Pubblicazione: (2021-12-01)
• Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors
  di: Ryotaro Ohkuma, et al.
  Pubblicazione: (2023-09-01)
• Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study
  di: Risako Suzuki, et al.
  Pubblicazione: (2025-12-01)